Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.8 USD | +3.32% | +0.72% | +12.00% |
05-02 | Transcript : Arbutus Biopharma Corporation, Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.00% | 511M | |
-3.44% | 88.14B | |
+1.45% | 40.51B | |
-14.43% | 31.67B | |
+51.20% | 24.62B | |
-14.85% | 15.65B | |
-13.87% | 12.07B | |
-7.87% | 11.97B | |
-39.40% | 11.61B | |
+5.62% | 8.81B |
- Stock Market
- Equities
- ABUS Stock
- News Arbutus Biopharma Corporation
- Arbutus Biopharma : Sets Out Clinical Objectives for 2021